Join
Live feed
·
PRReleasevia Quantisnow
Ventyx Biosciences Inc. logo

Ventyx Biosciences Announces Results from the Phase 2 Trial of VTX958 in Patients with Moderate to Severe Plaque Psoriasis and Provides Corporate Update

ByQuantisnow·Wall Street's wire, on your screen.
VTYX· Ventyx Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTYX (Ventyx Biosciences Inc.) and more on Quantisnow.